HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitafusion ‘Clinically Proven Absorption’ Claim Fails In C&D Appeal Of Industry Self-Regulation Review

C&D Also Argued NAD Erred In Initial Review Allowing Pharmavite To Expand Challenge

Executive Summary

Church & Dwight will comply with National Advertising Review Board decision to discontinue claim for vitafusion supplements. The panel rejected C&D’s argument that any amount of vitamin absorption is “clinically meaningful” and deferred to the National Advertising Division on C&D’s procedural challenge.

You may also be interested in...



Pharmavite Modifying Claims Challenged In Industry Self-Regulation Rapid Review

In response to Church & Dwight’s Single Well-defined Issue Fast Track challenge at NAD, Pharmavite modifies “clinically proven absorption” claims for Nature Made Multi Complete, Prenatal Multi + DHA Softgels, and Prenatal Gummies by disclosing nutrients clinically tested.

P&G Begins US Price Increases In Baby And Feminine Care, Could Expand To Health, Beauty

P&G plans up to double-digit price increases in US baby care, feminine care and adult incontinence and will analyze raw material costs and foreign exchange impacts in its other product categories for other pricing changes.

Same Old Supplement Claim Violations Prompt US Regulators’ Action Under New COVID-19 Authority

FTC files complaint against Quickwork as first action under authority granted in the COVID-19 Consumer Protection Act. The enforcement came after the firm twice ingored warnings to discontinue claims its vitamin D and zinc supplements were equal to or more effective than current vaccines.

Topics

Related Companies

UsernamePublicRestriction

Register

RS150398

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel